Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory And HTA Alignment Key To Attracting Investors To UK

Executive Summary

The COVID-19 pandemic has offered lessons on how collaboration can get important treatments to patients more quickly.

You may also be interested in...



UK’s NICE Seeks Feedback On Proposed Improvements To Its Processes

Proposals extend the health technology appraisal body's focus beyond final guidance to support for early development and real world performance.

NICE Reform Plans Aim To Help Make Post-Brexit UK A ‘First-Launch’ Country

Following a Brexit-induced delay over the summer, England's HTA body NICE has come up with a concrete set of proposals that it says will help it “robustly and efficiently” evaluate innovative technologies such as advanced therapies, histology-independent cancer treatments, and technologies for rare diseases. Industry bodies have welcomed the plans, which have just been put out for consultation.

Germany’s Confidential Pricing Move Could Protect Companies From Potential Trumpian US Reference Pricing

Confidential pricing would give companies more flexibility to negotiate discounts and prevent withdrawals.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS144411

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel